Psyence Group Inc. (CSE: PSYG)

Market Cap	2.80M
Revenue (ttm)	n/a
Net Income (ttm)	-65.89M
Shares Out	140.03M
EPS (ttm)	-0.48
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	20,000
Open	0.0200
Previous Close	0.0200
Day's Range	0.0200 - 0.0200
52-Week Range	0.0100 - 0.1200
Beta	2.31
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 8, 2024

About Psyence Group

Psyence Group Inc., a life science biotechnology company, engages in the cultivation and production of commercial psilocybin mushroom. It operates in two segments: Clinical Trial Activities and Non-Clinical Trial Activities. The company natural psilocybin is used for the treatment of a range of mental health disorders and other medical conditions. It also focuses on the development, distribution, and sale of over-the-counter non psilocybin containing functional mushroom nutraceutical products under the GOODMIND brand. The company was founded in...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 2019
• Country: Canada
• Stock Exchange: Canadian Securities Exchange
• Ticker Symbol: PSYG